2024 Conference Publication A phase 1 clinical trial of DB-020 intratympanic injections administered prior to high-dose cisplatin chemotherapy to reduce ototoxicityPanizza, Benedict J., O'Leary, Stephen John, Hart, Christopher David, Diwakarla, Chandra Sai, Barnett, Catherine, Lapuerta, Pablo, Lee, John, Raines, Shane, Quigley, Tera, Wolff, Heather M., Keilty, John, Ladwa, Rahul, Porceddu, Sandro V., McGrath, Margaret, Seetharamu, Nagashree, Fua, Tsien and Rischin, Danny (2024). A phase 1 clinical trial of DB-020 intratympanic injections administered prior to high-dose cisplatin chemotherapy to reduce ototoxicity. 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2024.42.16_suppl.6100 |
2023 Conference Publication High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC studyLadwa, R., Monkman, J., Sadeghirad, H., Cooper, C., Belz, G., Bowman, J., Schaider, H., Liu, H., Kulasinghe, A. and Porceddu, S. (2023). High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study. ESMO Congress 2023, Madrid, Spain, 20-24 October 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2023.09.2278 |
2023 Conference Publication A proteomic signature associated with prognosis in HPV-related locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC)Liu, Jia (Jenny), Jackson, Christopher, Anees, Asim, Noor, Zainab, Williams, Steven, Porceddu, Sandro, Liu, Howard, Ladwa, Rahul, Whitfield, Joseph, Reddel, Roger R., Zhong, Qing, Panizza, Benedict J. and Robinson, Phillip J (2023). A proteomic signature associated with prognosis in HPV-related locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC). 2023 ASCO Annual Meeting, Chicago, IL United States, 2-6 June 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.16_suppl.6055 |
2022 Conference Publication High-dimensional spatial phenotyping of cutaneous squamous cell carcinoma from immune-competent and immunocompromised patientsKulasinghe, Arutha, Jhaveri, Niyati, Klymyshyn, Dmytro, Cheikh, Bassem Ben, Ladwa, Rahul, Liu, Howard, Cooper, Caroline, Belz, Gabrielle, Porceddu, Sandro and Braubach, Oliver (2022). High-dimensional spatial phenotyping of cutaneous squamous cell carcinoma from immune-competent and immunocompromised patients. SITC 37th Annual Meeting (SITC 2022), Boston, MA United States, 8–12 November 2022. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2022-sitc2022.0079 |
2017 Conference Publication Sexual Behavior, HPV Status and P16 Expression in Oropharyngeal and Oral Cavity Squamous Cell Carcinoma PatientsEmmett, Sarah, Boros, Sam, Whiteman, David C., Porceddu, Sandro, Panizza, Benedict and Antonsson, Annika (2017). Sexual Behavior, HPV Status and P16 Expression in Oropharyngeal and Oral Cavity Squamous Cell Carcinoma Patients. COSA's 44th Annual Scientific Meeting, Immunotherapy: Molecules and Mountains, Sydney, NSW Australia, 13–15 November 2017. Hoboken, NJ United States: Wiley. |
2016 Conference Publication The use of predictive modeling in adaptive radiation therapy for head and neck cancerBrown, E., Owen, R., Harden, F., Mengersen, K., Oestreich, K., Houghton, W., Poulsen, M. G., Harris, S., Lin, C. and Porceddu, S. (2016). The use of predictive modeling in adaptive radiation therapy for head and neck cancer. Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, United States, Feb 18-20, 2016. Philadelphia, United States: Elsevier. doi: 10.1016/j.ijrobp.2015.12.069 |
2016 Conference Publication The influence of cisplatin de-escalation on survival outcomes in oropharyngeal head and neck squamous cell carcinoma (Ophnscc)Peters, G., McGrath, M., Porceddu, S. and Coward, J. (2016). The influence of cisplatin de-escalation on survival outcomes in oropharyngeal head and neck squamous cell carcinoma (Ophnscc). Implementation + Innovation in Immunotherapy, Surfers Paradise, Queensland, Australia, 3-5 August, 2016. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12540 |
2015 Conference Publication Using technology to deliver prophylactic swallowing therapy for HNC patients: Analysis of consumer perceptionsWall, L., Ward, E., Cartmill, B., Hill, A., Isenring, E., Byrnes, J. and Porceddu, S. (2015). Using technology to deliver prophylactic swallowing therapy for HNC patients: Analysis of consumer perceptions. Dysphagia Research Society 2015 Annual Meeting and Post-Graduate Course, Chicago, Illinois, USA, 11-14 March 2015. New York, NY United States: Springer. |
2015 Conference Publication Innovating Multidisciplinary Triage of Head and Neck Cancer Patients and Their Carers During (Chemo)Radiotherapy: the "screenit" SystemWall, Laurelie, Cartmill, Bena, Ward, Liz, Hill, Anne, Isenring, Elizabeth, Byrne, Joshua, Chambers, Suzanne, Dunn, Jeff, Nixon, Jodie, Whelan, Jane and Porceddu, Sandro (2015). Innovating Multidisciplinary Triage of Head and Neck Cancer Patients and Their Carers During (Chemo)Radiotherapy: the "screenit" System. COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart TAS, Australia, 17–19 November 2015. Hoboken, NJ United States: Wiley-Blackwell. |
2013 Conference Publication An International Survey of Definitive SABR for Extracranial Limited MetastasesLewis, S. L., Porceddu, S., Hoskin, P., Chmura, S., Moghanaki, D., Lo, S., Palma, D., Nakamura, N. and Salama, J. (2013). An International Survey of Definitive SABR for Extracranial Limited Metastases. 55th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Atlanta Ga, Sep 22-25, 2013. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.ijrobp.2013.06.1601 |
2013 Conference Publication Single agent panitumumab in patients with incurable cutaneous squamous cell carcinoma: A single centre phase II studyFoote, M., McGrath, M., Guminski, A., Hughes, B., Meakin, J., Thomson, D., Simpson, F. and Porceddu, S. (2013). Single agent panitumumab in patients with incurable cutaneous squamous cell carcinoma: A single centre phase II study. 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity, Amsterdam Netherlands, Sep 27-Oct 01, 2013. Oxford United Kingdom: Pergamon Press. doi: 10.1016/S0959-8049(13)70065-0 |
2012 Conference Publication Living with dysphagia: insights and implications for Speech Pathology Services for patients in the Survivorship Phase of head and neck cancerNund, Rebecca, Ward, Elizabeth, Scarinci, Nerina, Cartmill, Bena, Kuipers, Pim and Porceddu, Sandro (2012). Living with dysphagia: insights and implications for Speech Pathology Services for patients in the Survivorship Phase of head and neck cancer. COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho–Oncology, Brisbane QLD, Australia, 13-15 November 2012. West Sussex, United Kingdom: Wiley-Blackwell Publishing. |
2012 Conference Publication A study of human Papillomavirus (Hpv) 16 status in squamous cell carcinoma of the oropharynx in patients presenting to the head and neck cancer service Princess Alexandra Hospital, Brisbane, Queensland, AustraliaRowan, A., Porceddu, S., V, Pryor, D., I and Logan, J. (2012). A study of human Papillomavirus (Hpv) 16 status in squamous cell carcinoma of the oropharynx in patients presenting to the head and neck cancer service Princess Alexandra Hospital, Brisbane, Queensland, Australia. UCD School of Medicine & Medical Science, Summer Student Research Awards 2012, Dublin, Ireland, 4 October 2012. London, United Kingdom: Springer U K. doi: 10.1007/s11845-012-0861-2 |
2011 Conference Publication Estimation of EGF receptor expression and trafficking dysregulation in live tissue samples of cutaneous SCC and precursor lesionsGaffney, D. C., Barry, R., Lambie, D., Porceddu, S. V., Foote, M., Strutton, G., Saunders, N. A., Soyer, H. P. and Simpson, F. (2011). Estimation of EGF receptor expression and trafficking dysregulation in live tissue samples of cutaneous SCC and precursor lesions. Australasian College of Dermatologists Biennial Spring Conference 2011, Hobart, Australia, 13-16 October 2011. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-0960.2011.00810.x |
2011 Conference Publication A prospective examination of swallowing nutrition and patient-rated function following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancerCartmill, Bena, Cornwell, P., Ward, L.., Davidson, W. and Porceddu, S. (2011). A prospective examination of swallowing nutrition and patient-rated function following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer. Dysphagia Research Society 2011, San Antonio, TX USA, 3-5 March 2011. New York, NY USA: Springer New York. doi: 10.1007/s00455-011-9345-1 |
2010 Conference Publication Results of a prospective study of PET-directed management of the neck in node positive head and neck cancer following definitive radiotherapy with or without systemic therapyPorceddu, S., Pryor, D., Burmeister, E., Burmeister, B., Poulsen, M., Foote, M., Panizza, B., Logan, J., McFarlane, D. and Coman, W. (2010). Results of a prospective study of PET-directed management of the neck in node positive head and neck cancer following definitive radiotherapy with or without systemic therapy. 52nd Annual Meeting of the American-Society-For-Radiation-Oncology, San Diego, CA United States, 31 October - 4 November 2010. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.ijrobp.2010.07.275 |
2009 Conference Publication The Effect of Radiotherapy Dose and Volume on Relapse in Merkel Cell Cancer of the SkinFoote, M. C., Harvey, J., Porceddu, S., Dickie, G., Hewitt, S., Colquist, S., Zarate, D. and Poulsen, M. (2009). The Effect of Radiotherapy Dose and Volume on Relapse in Merkel Cell Cancer of the Skin. 51st Annual Meeting of the American-Society-for-Radiation-Oncology, Chicago, Il, United States, 1-5 November 2009. New York, NY, United States: Elsevier . |
2009 Conference Publication The emerging role of biomarker profiling and functional imaging for guidance of head and neck cancer managementPorceddu, S. V. (2009). The emerging role of biomarker profiling and functional imaging for guidance of head and neck cancer management. 2nd World Congress of the International-Academy-of-Oral-Oncology, Toronto, Canada, 8-11 July, 2009. AMSTERDAM: Elsevier; Pergamon. doi: 10.1016/j.oos.2009.06.055 |
2009 Conference Publication Results of a prospective PET-guided management of the neck study in node positive head and neck squamous cell carcinoma (HNSCC) following curative radiotherapy with or without concurrent chemotherapyPorcedduSV, PryorDI, DoughtonJ, BurmeisterE, BurmeisterBH and Poulsen, M. G. (2009). Results of a prospective PET-guided management of the neck study in node positive head and neck squamous cell carcinoma (HNSCC) following curative radiotherapy with or without concurrent chemotherapy. 2nd World Congress of the International Academy of Oral Oncology, Toronto, Canada, 8-11 July, 2009. AMSTERDAM: Elsevier; Pergamon. doi: 10.1016/j.oos.2009.06.110 |
2005 Conference Publication Aggressive cutaneous squamous cell carcinoma (SCC) in chronic lymphocytic leukaemia (CLL)Lane, S. W., Mollee, P. N., Bird, R., Porceddu, S. and Gill, D. (2005). Aggressive cutaneous squamous cell carcinoma (SCC) in chronic lymphocytic leukaemia (CLL). 47th Annual Meeting of the American Society of Hematology, Atlanta, GA, United States, 10-13 December 2005. Washington, DC, United States: American Society of Hematology. |